Where does Decibel Therapeutics, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Decibel Therapeutics, Inc. ranks #26,110 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Decibel Therapeutics, Inc. hold?

Decibel Therapeutics, Inc. holds 10 US utility patents granted between 2020 and 2025, spanning 7 technology areas.

What is Decibel Therapeutics, Inc.'s Innovation Score?

Decibel Therapeutics, Inc. has an Innovation Score of 36.7 out of 100 (top 46% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Decibel Therapeutics, Inc. focus on?

Decibel Therapeutics, Inc.'s top technology area is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes) with 10 patents, ranking #2,196 of 7,163 assignees active in that subclass. Grants appear in 7 CPC subclasses total.

Is Decibel Therapeutics, Inc.'s patent grant rate increasing or decreasing?

Insufficient historical data is available to calculate a velocity trend for Decibel Therapeutics, Inc..

What does claim depth mean for Decibel Therapeutics, Inc.'s patents?

Decibel Therapeutics, Inc.'s patents average 16.9 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Decibel Therapeutics, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Decibel Therapeutics, Inc.

USPTO PatentsView assignee record - 10 granted patents across 7 technology areas, recorded in grant years 2020–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61K (Preparations FOR Medical, Dental OR Toiletry Purposes).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Decibel ranks #26,110 of 49,997 tracked US assignees by granted-patent volume, with 10 patents across 7 technology areas.

#26,110
of 49,997 US assignees by volume: Top 46%
by Innovation Score (36.7/100): 16.9
avg claims per patent

USPTO PatentsView assignee plate

Corpus R26110 · US Corporation #26,110 · 10 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · SPAN-YRS · BOOK-RICH

GRANTS-MICRO 10 grants
MID-PACK #26,110/49,997
PHOTO-FINISH Datalogic Automation
CPC-NARROW A61K · 7 areas
INNOV-THIN 36.7/100
CLAIMS-RICH 16.9 claims/avg
TYPE-USCORP US Corporation
SPAN-YRS 2020–2025 · 6y
BOOK-RICH 9/10 fields

Nearest grant-volume peer: Datalogic Automation, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Decibel’s 36.7 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 8.3 pts (23%) Velocity 8.9 pts (24%) Breadth 9.4 pts (26%) Claim depth 10.1 pts (28%)

Qualcomm Incorporated · highest

85
Decibel Therapeutics · this assignee

37
3D Lighting… · lowest

7

What this shows Decibel's Innovation Score is 36.7/100 (top 46% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Decibel?

Each dot is one of Decibel’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Decibel’s own 16.9 claims/patent is at or below the 18.7 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Decibel vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Decibel's grants concentrate

Decibel Therapeutics, Inc. is a focused PatentsView assignee: 7 CPC subclasses with 100% of grants classified under A61K (Preparations FOR Medical, Dental OR Toiletry Purposes). Peak complete grant year is 2020 (2 grants) versus a trough of 1 in 2021. By volume, Decibel sits between DataShapes, Inc. and Destiny Software Productions Inc..

Decibel's three-year grant acceleration

Decibel Therapeutics, Inc. shows 4 grants in 2022–2024 against only 3 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Datashapes

10
Datalogic Automat…

10
Datorama

10
Daymen US

10
Defender Screens…

10
Delta-fly Pharma

10
Design Blue

10
Destiny Software…

10
Decibel Therapeut… ◀

10

What this shows Decibel holds 10 patents at rank #26,142, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Decibel

By rank, the assignees closest to #26,142 in granted patent volume.

Leaders in A61K (Preparations FOR Medical)

Other assignees with the most granted patents in Decibel's primary technology class.

Decibel's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

37 Top 46% higher than 54% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2020–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2020–2019 baseline. Full figures in the table below.

View data table

Decibel Therapeutics, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2020	2	20.0%
2021	1	10.0%
2022	1	10.0%
2023	2	20.0%
2024	1	10.0%
2025partial year	3	30.0%

Which technologies does Decibel Therapeutics, Inc. patent most?

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 10

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 5

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 5

C07K - Peptides 4

C12Y - Enzymes 1

A01K - Animal HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; Rearing OR Breeding Animals, NOT Otherwise Provided FOR; NEW Breeds OF Animals 1

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 1

Top 7 of 7 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Decibel Therapeutics, Inc.'s patent record in context - here's where to go next.

Decibel Therapeutics, Inc.'s lead technology class is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes), 100% of its portfolio - see every assignee active in that class. Explore A61K
Ranked #26,110 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Decibel Therapeutics, Inc. against DataShapes, Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 36.7/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.